US 11198689
Compositions and methods for inhibition of the JAK pathway
granted A61KA61K31/343A61K31/436
Quick answer
US patent 11198689 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/343, A61K31/436, A61K31/505, A61K31/506